Free Newsletter
Tool provider bridges paper, electronic data
Dermatology-focused CRO Symbio has tapped e-clinical tools provider DATATRAK for an effort that combines paper-based and electronic trial data. Symbio will use DATATRAK eClinical's hybrid functionality--double data entry and EDC--in a Phase III rescue study for an unnamed client.
The CRO will enter paper-based study records via its eClinical data management component. Patient data from the rescue study, meanwhile, will be captured electronically via the EDC component. Data captured during the rescue study will then be added to the initial study data converted from paper to electronic form. The effort is intended to let researchers capitalize on data that might previously have been unusable.
"The eClinical component will let us provide real time data to the sponsor and streamline the data capture activities from the sites," says Betsey Zbyszynski, Symbio director for Client Services.
As reported earlier, some industry watchers expect more than half of this year's new trials to use electronic data capture technology.
- here's the announcement
- see our earlier EDC coverage
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession




